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                                          ABSTRACT 
 
Background: Seizures beginning in adult life are likely to be an identifiable cause 
as compared to those beginning in childhood which are more likely to be 
idiopathic. 
Objectives: To study the clinical profile and analyze the etiological agents of  New 
Onset Seizures. 
Material and Methods:  This Descriptive study done in the KMC hospital to 
know the  various etiologies in patients presented with new onset seizures.In these 
cases  history and clinical examination and special investigations like CT BRAIN, 
MRI BRAIN,EEG, SEROLOGY, CSF ANALYSIS were done to find out the 
etiology. 
Results: Out of 100 patients 55% were males,45%were females with male to 
female ratio of 1.2:1.Majority of males were in 2
nd
 decade and females were in 4
th
 
decade.Patients age ranged from 18 yrs to 80 yrs,with the mean of  40.11years with 
77% of the patients were in the below 50 yrs. Alcohol withdrawal  was the leading 
cause of seizures which account for 34% followed by idiopathic seizures 
(29%),neuro infection (16%),CVA 12% and metabolic (9%). 
Conclusion: Alcohol withdrawal is the most common cause of seizure in new 
onset seizure patients who coming to KMCH.  
Keywords: New onset seizure, Alcoholwithdrawal,Tuberculoma, 
Neurocysticercosis,Meningitis,  Metabolic seizure. 
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                                        INTRODUCTION 
 
        Epilepsy describes a condition in which a person has recurrent seizures due to 
chronic underlying process.. 
Epilepsy of late onset (Epilepsia tarda, late onset epilepsy) may be simply 
defined as epilepsy beginning in adult life. 
Epilepsy beginning in adult life is due to progressive brain disease as 
compared to idiopathic epilepsy, which has, it’s onset in childhood or adolescence. 
With  proper history and clinical examination, analysis of etiology is made 
with available investigations, the epilepsy can be treated accordingly thus reducing 
the morbidity and mortality associated with it. 
Hence, this study is aimed to evaluate the clinical profile and etiological 
analysis of new onset epilepsy in adults of more than 18 years of age. 
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                                  REVIEW OF LITERATURE 
HISTORY OF EPILEPSY : 
A seizure (from the Latin sacire, " to take possession of ") is a paroxysmal event 
due to abnormal excessive or synchronous neuronal activity in the brain. 
From the Greek word ―epilambanein ‖ the term ―epilepsy‖ comes which 
means ―to seize‖ or ― to take hold of ‖. 
Approximately 500 years before Hippocrates, Atreya, the father of Indian 
Medicine, recognized that disturbance of mind is epilepsy, rather than an effect of 
supernatural phenomena. Hippocrates, in his book ―on the scared disease‖noted, 
―The brain is the seat of epilepsy as it is of every violent disease‖. 
The idea that epilepsy was caused by demons, humors, and toxic substances 
persisted through the middle ages. 
 The ideas of supernatural causation slowly died out only to be replaced by 
another set of bizarre misnomers. Obstetrician to Queen Victoria, Sir Charles 
Locock, Credited crowded teeth, menstruation and masturbation with causing 
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seizures. Dr.Locock pioneered the use of potassium bromide the first modern 
antiepileptic drug treatment.He had found that women with ―hysterical‖seizures 
associated with menstruation,was thought to curb the sexual desires. 
In 1857 after the start of bromide treatments, modern epilepsy treatment 
proceeded at a quick pace. In 1912 Phenobarbitone was introduced and 24 years 
later to that, pioneer work on phenytoin was carried out. Drugs like 
Carbamazepine, sodium valproate and vigabatrin followed in 1954, 1973 and 1990 
respectively. Now people with seizures are confronted with an array of confusing 
but it often effective, treatments. 
We can look forward in future to a deeper understanding of alternative 
treatments and advances in diagnosis and treatment through progress in surgery 
,biochemistry,and possibly even neural grafts and molecular genetics
(1)
. 
EPIDEMIOLOGY  OF  EPILEPSY 
 PREVALENCE : 
               It  is the proportion of people with seizure in given population at a 
specified time. The worldwide prevalence of active seizure is between 4-10 per 
1000 population
(2)
. The prevalence rate in India is 5.59 per 1000.There is no 
statistically different rates between  women and men or urban and rural 
residence
(3)
. 
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INCIDENCE:  
The number of new cases of seizure occurring during a given time interval, 
usually one year, in a specified population is called as incidence. Incidence rate 
varies from 38 to 49.3 per 1, 00,000 population per year from two community 
based studies in India.
(4) 
Type of seizure pattern showed maximum number of cases belonged to 
generalized seizures, which is different from western countries where partial 
seizure is the commonest variety. (The proportion of generalized seizures and 
partial seizures was 58.8% and 30.6% respectively)
(5)
.
 
The prognosis for seizure control is good and over 70% will enter remission. 
There is an increased risk of premature death particularly in patients with chronic 
epilepsy
(6)
. 
 
DIAGNOSIS OF EPILEPSY 
       It is rare to observe a seizure directly at the first medical examination or at an 
outpatient clinic. The confirmation and diagnosis of the seizure type usually based 
on the history taken from the patients or caregivers. First we have to distinguish 
epileptic seizures from the non- epileptic attacks, such as psychogenic seizures and 
syncopal attacks. In distinguishing a syncopal attack from an epileptic seizure, we 
must pay attention to the sensation of faintness or feeling of ―blackouts‖ 
immediately before loss of consciousness and the presence of provoking factors, 
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such as noxious stimuli, sudden unexpected pain or standing for a long time,. Next 
we must ask the following questions directly to the patients or indirectly to the care 
givers to make a precise seizure diagnosis including the aura, asymmetry of the 
seizures, content, clouded consciousness, presence of automatism, deviation of the  
head  and eyes and a dystonic arm posture
(7)
. 
        A fundamental principle is that seizures may be either  focal or generalized. 
Generalized seizures involve diffuse regions of the brain simultaneously. Focal 
seizures are those in which the seizure activity is restricted to discrete areas of the 
cerebral cortex. Generalized seizures may result from biochemical, cellular 
abnormality or structural abnormalities that have a more widespread distribution. . 
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In contrast, focal seizures are usually associated with structural abnormalities of 
the brain. 
Focal Seizure 
      Focal  seizures  arise  from  a  neuronal  network  either  discretely  localized 
within  one  cerebral  hemisphere  or  more  broadly  distributed  but  still  within 
the  hemisphere.The  new  classification  system,  described it as focal seizures 
with or without dyscognitive features. 
         Focal seizures can also evolve into generalized seizures. In the past this was 
referred to as focal seizures with secondary generalization, but the newer system 
relies on specific descriptions of the type of generalized seizures that evolve from 
the focal seizure. 
Focal Seizures Without Dyscognitive Features 
           Focal seizures can cause autonomic, motor, sensory or psychic symptoms 
without impairment of cognition.The EEG recorded with scalp electrodes during 
the seizure may show abnormal discharges in a very limited region over the 
appropriate area of cerebral cortex if the seizure focus involves the cerebral 
convexity. Seizure activity from deeper brain structures is often not recorded by 
the standard EEG, it may require intracranial electrodes for its detection. 
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      Three additional features of focal motor seizures are,  
1. In some patients the abnormal motor movements may begin in a very 
restricted region such as the fingers and gradually progress to include a 
larger portion of the extremity. This phenomenon known as a "Jacksonian 
march" which represents the spread of seizure activity over a progressively 
larger region of motor cortex.  
2. Patients may experience a localized paresis (Todd's paralysis) for minutes to 
many hours in the involved region following the seizure.  
3. In rare instances the seizure may continue for hours or days.It termed 
epilepsia partialis continua, also it is often refractory to medical therapy. 
      Focal seizures may also manifest as changes in vision (flashing lights or 
formed hallucinations), equilibrium (sensation of falling or vertigo), or autonomic 
function (flushing, sweating, piloerection) somatic sensation (e.g., paresthesias). 
Focal seizures arising from the temporal or frontal cortex may also cause 
alterations in olfaction, hearing, or higher cortical function sensation of unusual, 
intense odors (e.g., burning rubber or kerosene) or an epigastric sensation that rises 
from the stomach or chest to the head. Patients describe odd, internal feelings such 
as  fear, detachment,  a sense of impending change, depersonalization, déjá vu, or 
illusions that objects are growing smaller (micropsia) or larger (macropsia). These 
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subjective, "internal" events that are not directly observable by someone else are 
referred to as auras. 
Focal Seizures with Dyscognitive Features 
        Focal seizures accompanied by a transient impairment of the patient's ability 
to maintain normal contact with the environment. These patients unable to respond 
appropriately to verbal or visual  commands during the seizure and has impaired 
awareness or recollection of the ictal phase. Seizures frequently begin with an aura 
that is stereotypic for the patient. The start of the ictal phase is a sudden behavioral 
arrest or motionless stare. The behavioral arrest is usually accompanied by 
automatisms, which are involuntary, automatic behaviors such as chewing, lip 
smacking, swallowing, or "picking" movements of the hands, or elaborate 
behaviors such as a display of emotion or running. These patients typically 
confused following the seizure, and the full recovery of consciousness may range 
from seconds up to an hour. Immediately following the seizure may show 
anterograde amnesia or, in cases involving the dominant hemisphere, a postictal 
aphasia. 
Evolution of Focal Seizures to Generalized Seizures:   Focal seizures can spread 
to involve both cerebral hemispheres and produce a  generalized seizure, usually of 
the tonic-clonic variety . This evolution is observed  following focal seizures 
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arising from a focus in the frontal lobe, but may also be associated with  focus 
elsewhere in the brain. A focal seizure that evolves into a generalized seizure is 
often difficult to distinguish from a primary generalized-onset tonic-clonic seizure. 
Generalized Seizures 
        Generalized seizures are arise at some point in the brain but immediately and 
rapidly that engage neuronal networks in both cerebral hemispheres.. 
Typical Absence Seizures 
       It characterized by sudden, brief lapses of conscious without loss of postural 
control. It typically lasts for only seconds, consciousness returns as suddenly as it 
was lost, and there is no postictal confusion. It usually accompanied by 
subtle,bilateral motor signs such as chewing movements, rapid blinking of the 
eyelids, or small-amplitude, clonic movements of the hands. In typical absence 
seizures the onset usually in childhood (ages 4–8 years) or early adolescence and 
are the main seizure type in 15–20% of children with epilepsy. Seizures can occur 
100 of times per day, but the child may be unaware or unable to convey their 
existence. Absence epilepsy is often unexplained "daydreaming" and a decline in 
school performance recognized by a teacher. The EEG of typical absence seizures 
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is a generalized, symmetric, 3-Hz spike - and - wave discharges that begins and 
ends suddenly, superimposed on a normal EEG background. 
Atypical Absence Seizures 
   The loss of consciousness is usually of  longer duration  and slow in onset and 
cessation.It also associated with motor signs that includes focal or lateralizing 
features.EEG shows a generalized,2.5Hz slow spike-and-wave pattern.These are 
usually associated with diffuse or multifocal structural abnormalities of the 
brain.So associated with other signs of neurologic dysfunction such as mental 
retardation.Atypical absence seizures are less responsive to anticonvulsants 
compared to typical absence seizures. 
Generalized, Tonic-Clonic Seizures 
         These are the main seizure type in 10% of all persons with epilepsy.Also a 
common seizure type resulting from metabolic derangements. The seizure usually 
begins abruptly without warning. The initial phase is usually tonic contraction of 
muscles throughout the body. Tonic contraction of the muscles of expiration and 
the larynx will produce a loud moan or "ictal cry." Contraction of the jaw muscles 
may cause biting of the tongue. After 10–20 seconds, the seizure typically evolves 
into the clonic phase, produced by the periods of muscle relaxation on the tonic 
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muscle contraction. It progressively increase until the end of the ictal phase. The 
postictal phase is characterized by muscular flaccidity, unresponsiveness, and 
excessive salivation. Bladder or bowel incontinence may occur. Patients gradually 
regain consciousness over minutes to hours, and in this transition there is typically 
a period of postictal confusion. The duration of unconsciousness in the postictal 
phase can be extremely long in patients with prolonged seizures or underlying 
CNS diseases such as alcoholic cerebral atrophy.The EEG during the tonic phase 
shows a progressive increase in generalized low-voltage fast activity, followed by 
high-amplitude, polyspike discharges. The high-amplitude activity is interrupted 
by slow waves to create a spike-and-wave pattern in the clonic phase.  
Atonic Seizure  
These are characterized by sudden loss of postural muscle tone lasting 1–2 
seconds. Brief impairment in Consciousness, but there is usually no postictal 
confusion. The EEG shows brief, generalized spike-and-wave discharges followed  
by diffuse slow waves that correlate with the loss of muscle tone. 
Myoclonic Seizures 
          Myoclonus is a sudden and brief muscle contraction that may involve one 
part of the body or the entire body. A common physiologic form of myoclonus is 
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the sudden jerking movement observed during asleep. Pathologic myoclonus is 
commonly seen in association with anoxic brain injury, metabolic disorders and 
degenerative CNS diseases. The EEG shows bilaterally synchronous spike-and-
wave discharges synchronized with the myoclonus
 
Juvenile Myoclonic Epilepsy 
It  is a generalized seizure disorder of unknown cause that occurs in early 
adolescence.It is usually characterized by single or repetitive bilateral myoclonic 
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jerks. The myoclonic seizures can be provoked by sleep deprivation and most 
frequent in the morning after awakening. Consciousness is preserved unless the 
myoclonus is especially severe.  
Lennox-Gastaut Syndrome 
         It  occurs in children and is defined by the following triad: (1) multiple 
seizure types (including atonic, generalized tonic-clonic and atypical absence 
seizures); (2) impaired cognitive function in most but not all cases,(3) an EEG 
showing slow (<3 Hz) spike-and-wave discharges.It is associated with CNS 
disease or dysfunction due to developmental abnormalities, trauma, infection,  
perinatal hypoxia/ischemia, and other acquired lesions. Many patients have a poor 
prognosis due to the underlying CNS disease. 
Mesial Temporal Lobe Epilepsy Syndrome 
   It is the most common syndrome associated with focal seizures with 
dyscognitive. High-resolution MRI can detect hippocampal sclerosis that appears 
to be essential in the pathophysiology of MTLE for many patients. 
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The Causes of Seizures and Epilepsy  
         Shift in the normal balance of excitation and inhibition within the CNS 
causes seizures. Three clinical observations emphasize how a variety of factors 
determine why certain conditions may cause seizures or epilepsy in a given patient. 
   1) The normal brain is capable of having a seizure under the appropriate 
circumstances, and individuals vary in the susceptibility or threshold for seizures. 
For eg, seizures may be induced by high fevers in children who are otherwise 
normal and they may  never develop other neuro logic problems, including 
epilepsy.Febrile seizures occur only in a relatively small proportion of children.It 
implies there are various underlying, endogenous factors which influence the 
threshold for having a seizure. 
     2) There are varieties of conditions that have an extremely high likelihood of 
resulting in a chronic seizure disorder. One of the examples of this is severe, 
penetrating head injury, which is associated with upto a 45% risk of subsequent 
epilepsy.A process is known as epileptogenesis which is, high propensity for 
severe traumatic brain injury lead to epilepsy suggests that the injury results in a 
long-lasting, pathologic changes in the CNS that transforms a presumably normal 
neural network into a abnormally hyperexcitable. Other processes associated with 
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epileptogenesis include  infections,  stroke, and abnormalities of CNS 
development. 
3) Seizures are episodic. Patients with epilepsy have seizures 
intermittently.Depending on the underlying cause, many patients are completely 
normal for months to years between seizures. It shows there are important 
precipitating or provocative factors that induce seizures in patients with epilepsy. 
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Causes According to Age 
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a
In benzodiazepine-dependent patients. 
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Mechanisms of Seizure Initiation and Propagation 
     Focal seizure activity can begin in a discrete region of cortex and then spread to 
neighboring regions. There is a seizure initiation phase followed by a seizure 
propagation phase. 
Initiation phase characterized by the following the two concurrent events, 
(1) high-frequency bursts of action potentials and (2) hypersynchronization.   
       The bursting activity is caused by a long-lasting depolarization of the neuronal 
membrane due to influx of extracellular Ca
2+
,this leads to the opening of voltage-
dependent Na
+
channels, influx of Na
+
 & generation of repetitive action potentials.  
Followed by a hyperpolarizing afterpotential mediated by GABA receptors or K
+
 
channels, depending on the cell type. The spike discharge on the EEG is due to 
synchronized bursts from a sufficient number of neurons.Normally, intact 
hyperpolarization and a region of "surround" inhibition created  by Inhibitors 
prevents the spread of bursting activity. There is a recruitment of  surrounding 
neurons via one of the following four mechanisms, including: 
1)An increase in extracellular potassium, which blunts hyperpolarization and 
depolarizes neighboring neurons; 
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(2) Enhanced neurotransmitter release due to accumulation of calcium in 
presynaptic terminals; 
(3) Depolarization-induced activation of the NMDA receptor, which causes 
additional calcium influx and neuronal activation;  
(4) Changes in tissue osmolarity and cell swelling.  Propagation of seizure  
activity into contiguous areas via local cortical connections due to recruitment of a 
sufficient number of neurons and to distant areas through the long commissural 
pathways such as the  corpus callosum. 
          Accidental ingestion of domoic acid, which is an analogue of glutamate 
causes profound seizures via direct activation of excitatory  receptors throughout 
the CNS. Commonly used Penicillin, which can lower the seizure threshold in 
humans but  in experimental models it reduces inhibition by antagonizing the 
effects of GABA and act as a potent convulsant.  
Basic mechanisms of other precipitating factors of seizures such as fever,  alcohol 
withdrawal, infection, sleep deprivation and hypoxia are not as well understood. 
The generalized spike-and-wave discharges in absence seizures is due  to 
oscillatory rhythms which is normally generated during sleep by the circuits 
connecting the thalamus and cortex. This involves an interaction between GABAB 
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receptors, T-type calcium channels, and potassium channels located within the 
thalamus. This modulation of these receptors and channels can induce absence 
seizures. 
       Alcohol causes intoxication through effects on diverse ion channels and 
neurotransmitter receptors, including GABAA receptors—particularly those 
containing δ subunits that are localized extrasynaptically and mediate tonic 
inhibition and N-methyl-D-aspartate (NMDA) receptors.  
    Alcohol dependence results from compensatory changes during prolonged 
alcohol exposure, including internalization of GABAA receptors, which allows 
adaptation to these effects.  
      Withdrawal seizures are due to reflect unmasking of these changes and may 
also involve specific withdrawal-induced cellular events, such as rapid increases in 
α4 subunit–containing GABAA receptors that confer reduced inhibitory function. 
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Management of Seizures : 
History and Examination 
The first goal is to determine whether the event was a true seizure. An in-depth 
history is important, for in many cases the diagnosis of a seizure is based solely on 
clinical grounds—the examination and laboratory studies are often normal. 
Focused on the symptoms before, during, and after the episode of seizure the 
questions should be asked, in order to differentiate a seizure from other paroxysmal 
events. 
     The history should also focus on predisposing events and  risk factors. 
Epileptogenic factors such as prior stroke, head trauma, tumor, or CNS infection 
should be identified. History of febrile seizures, brief seizures not recognized as 
such,earlier aura and a family history of seizures should be asked to get a clues 
regarding predisposition.Ask for developmental milestones in children,it may 
provide evidence for underlying CNS disease. Precipitating factors such as 
systemic diseases,  sleep deprivation, electrolyte or metabolic derangements, drugs 
that lower the seizure threshold, acute infection, or illicit drug or alcohol use 
should also be identified. 
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On general examination look for signs of infection or systemic illness. Look for 
signs of neurocutaneous disorders such as neurofibromatosis,  tuberous sclerosis or 
chronic liver or renal disease. Presence of organomegaly may indicate a metabolic 
storage disease.Presence of  limb asymmetry may gives a clue to brain injury early 
in development. Look for signs of head trauma, alcohol or illicit drugs uses. 
Auscultation of the CVS and carotid arteries may help to identify an abnormality 
that predisposes to cerebrovascular disease. 
All patients need  a complete neurologic examination. Careful assessment of 
mental status (including memory, abstract thinking, language function) may 
suggest lesions in the anterior frontal, temporal or parietal lobes. Testing of visual 
fields will help to screen for lesions in the optic pathways and occipital 
lobes.Pronator drift,abnormal deep tendon reflexes, gait, and inco-ordination may 
suggest lesions in motor (frontal) cortex, and cortical sensory testing may detect 
lesions in the parietal cortex. 
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LABORATORY EVALUATION : 
Routine blood investigations are indicated to identify the common metabolic 
causes of seizures like abnormalities in electrolytes, glucose, magnesium or 
calcium, and hepatic or renal disease. A screen for toxins in urine and blood should 
also be obtained when no clear precipitating factor has been identified. A lumbar 
puncture is indicated in suspicion of meningitis or encephalitis and even in the 
absence of symptoms or signs suggesting infection it is mandatory in all patients 
infected with HIV. 
Electroencephalography(EEG): 
By recording from electrodes placed on the scalp, the EEG measures 
electrical activity of the brain. The potential difference between pairs of electrodes 
is amplified and displayed on a computer monitor, oscilloscope, or paper. The 
characteristics of the normal EEG depend on the patient's level of arousal and age. 
The recorded activity is the postsynaptic potentials of pyramidal cells in the 
cerebral cortex and is characterized by its frequency. 
The EEG is best recorded by several different electrode arrangement in turn, 
and the  following activating procedures  like hyperventilation (for 3 or 4 min), 
sleep, sleep deprivation on the night pior to the recording  and photic stimulation 
are usually performed in an attempt to provoke abnormalities. 
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In  a patient with suspected epilepsy during evaluation, the presence of 
electrographic seizure activity like abnormal, repetitive, rhythmic activity with an 
abrupt onset and termination, clearly establishes the diagnosis. But , absence of 
electrographic seizure activity does not exclude a seizure disorder. Because simple 
or complex seizures may originate from a region of cortex that is not within range 
of the scalp electrodes. During generalized tonic – clonic seizures the EEG is 
always abnormal.  
The EEG may also be supportive of the diagnosis of epilepsy during  the 
inter-ictal period by showing certain abnormalities. Epileptiform activity consists 
of bursts of abnormal discharges containing spikes or sharp waves.The EEG is also 
used for classifying seizure disorders and for the selection of anticonvulsant 
medications . The routine scalp - recorded EEG is also used to assess the prognosis 
of seizure disorders; A normal EEG implies a better prognosis, whereas profuse 
epileptiform activity suggests a poor outlook. 
Brain Imaging 
        Patients with new- onset seizures should have a brain imaging study to rule 
out an underlying structural abnormality that is responsible . For the detection of 
cerebral lesions associated with epilepsy MRI has been shown to be superior to 
computed tomography (CT). MRI will identify lesions such as vascular 
malformations, tumors, or other pathologies that need immediate therapy. Fluid- 
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attenuated inversion recovery (FLAIR) is the newer MRI method, which has 
increased the sensitivity for detection of abnormalities of cortical architecture like  
abnormalities of cortical neuronal migration and hippocampal atrophy associated 
with mesial temporal sclerosis. In such cases, they do provide an explanation for 
the patient's seizures and point to need for  possible surgical resection or the need 
for chronic anticonvulsant therapy . 
ADULT ONSET IDIOPATHIC GENERALIZED EPILEPSY (AIGE) 
  It is generally thought to have a  focal basis and symptomatic 
etiology
(8)
.  However in some  patients, IGE is suspected because of typical 
generalized tonic - clonic, myoclonic or absence  seizures, a family history of 
seizures, the generalized spike- wave complexes on EEG, normal brain 
imaging
(9)
.Two hospital based studies recently reported that 34.8% and 13.4%  of 
IGE cases had seizure onset in adulthood
(10,11)
 .The  IGE typically appears within 
first two decades of life. 
The annual age specific incidences of IGE patients aged 15- 24 years were 
3.6 per 1,00,000 and 25- 34 years were 3.5 per 1,00,000.Whereas the incidences of 
IGE patients aged 5- 9 years were 10.7 per 1,00,000 and 10- 14 years were 15.3 
per 1,00,000
(12)
.Patients with AIGE  have a good prognosis, with  good to excellent 
seizure control
 
 with a single AED
(13) 
. 
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The patients with AIGE can be divided into three groups on the basis of seizure 
type
 
1) Adult onset absence epilepsy: absence seizures as well as tonic – clonic seizures 
occurs in these patients. 
2) Adult onset myoclonic epilepsy: myoclonic jerks and tonic- clonic seizures 
occurs in these patients. 
3) Adult onset tonic – clonic epilepsy: only tonic clonic seizures occurs in these 
patients 
 
POSTSTROKE EPILEPSY :  
       Most frequent causes of seizures in adulthood, particularly in the old age is 
stroke. Incidence of seizures after stroke varies from 4.1% to 12.5%
(14)
. Post 
stroke epilepsy incidence in India is13%
(15)
. 
Temporal relation of stroke and seizures: Seizure may occur before or at the 
onset of or weeks to months after a stroke.  
      The incidence of epilepsy prior to stroke was 4.5% when compared to 0.6% in 
the matched control group
(16)
. These seizures occur weeks or even years before the 
presenting stroke. This increased incidence of epilepsy in stroke patients may be 
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attributed to subclinical cerebral vascular disease Thus, the onset of seizures in 
adult or elderly population may be warning sign for further strokes.  
Post stroke seizures classification:  
Early onset seizures: seizures occurring within 2 weeks following stroke onset 
Late onset seizures: seizures  occurring after 2 weeks. This differentiation helps to 
determine the need and duration of treatment these patients with an AED’s(14). 
POST STROKE EARLY SEIZURES: 
The  incidence of epileptic seizures in acute stroke is 4.4% in patients with 
transient ischemic attacks (TIA), lobar infarcts  and extensive hemorrhages. 
Seizures occur within 24 to 48 hours after the stroke. In a prospective study of 
1000 patients with stroke and TIA the incidence of early seizures was  (15.4%) in 
patients with supratentorial lobar or extensive  hemorrhages, followed by  
SAH(8.5%), carotid artery cortical infarction (6.5%), and hemispheric TIA’s 
(3.7%)
(18)
.The commonest site of infarction among the patients with cortical 
infarcts and early epilepsy is in the MCA territory. Predictably, subcortical and 
deep cerebral, brain stem infarcts, and infratentorial hemorrhages are not 
associated with increased risk for seizures. Incidence of seizures is low (1%) in 
lacunar infarcts. Cerebral embolism patients experience more seizures than 
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thrombotic infarct patients
(19)
. Patients with stroke and early seizures had larger 
lesions(>10 mm) on cerebral CT scan. In acute stage, almost 60% of seizures are 
focal and 40% are of generalized tonic - clonic type. Of the focal seizures, 75% are 
simple focal motor while remaining 25% become generalized. In 0.7 to 1.1% of 
patients with stroke early seizures presenting with status epilepticus (SE). 
Predictive factors of early seizures: 
         The presence of precipitating factors like hypoglycemia, 
hyperglycemia,  hypernatremia ,hyponatremia, hypomagnesemia, hypocalcemia, 
infections and renal failure increases the incidence of seizures. Increased risk of 
early seizures also been found in patients with history of diabetes and atrial 
fibrillation. However, the major predictors of early seizures in new onset stroke 
patients are cortical involvement in neuro- imaging studies, initial stroke severity 
and acute confusional state at the onset of stroke
(20)
. Primary generalized seizure is 
common with late onset seizures (56%).But early onset seizures, which are 
generally simple partial in nature.Status epilepticus is more common in early onset 
than late onset seizures.
(24)
 
 
 
 
 
31 
 
Pathophysiology of early post stroke seizures: 
          In infarct, in the ischemic penumbra ionic imbalances, enhanced release of 
excitotoxic glutamate, breakdown of membrane phospholipids and release of FFA 
play an important role in epileptogenesis
(14)
. 
Risk of recurrence – There is 11% to 39% risk of recurrent seizures in patients 
with early stroke  seizures. Lesions involving more than one lobe, patients with 
large hemorrhagic strokes, and cortical infarcts are at higher risk of developing 
seizures later
(21)
. 
Management:  
Seizures can be controlled with  monotherapy alone. 
(22) 
If the stroke patient presents with status epilepticus or if there is early recurrence of 
seizures treatment with AED therapy is indicated. 
POST STROKE LATE SEIZURES: 
It occur after first 2 weeks of stroke.It also may begin months to a year after 
a stroke. The incidence  is about 15%
(23)
. Nearly 24% of seizures occur within 
three weeks and 93% in two years. 
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Pathophysiology of late post stroke epilepsy:    it occurs due to structural brain 
abnormalities leading to the development of an epileptic focus.  
Management:  
      Carbamazepine and Phenytoin have high treatment success in post stroke 
epilepsy.
 
SINGLE SMALL ENHANCING CT LESIONS (SSECTL)
 
In Indian patients with new onset seizures the commonest imaging 
abnormality is spontaneously resolving  single, small, enhancing lesion in CT
(25)
. 
   Atleast 26% of Indian patients with focal epilepsy have SSECTL reported by 
Wadia et al
(26)
 . The lesion could have either a disc or a ring like enhancement of 
size less than 20mm. The surrounding perifocal oedema may be mild to moderate 
and usually there is no mass effect.
 
In 1985 Setiet al
(27)
, however reported the 
spontaneous resolution of these lesions. 
 
             
By the help of stereotactic brain biopsy Rajshekar et al
(28)
 have made an 
attempt to answer the controversy regarding the etiology of these lesions. He 
showed after histopthological diagnosis that, majority of these lesions are 
cysticercus granuloma and few of them are tuberculoma. They form the clinical 
and radiological criteria of SSECTL to diagnose the lesion to be a solitary 
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cysticercus granuloma.These lesions itself  acts as antigen and production of 
inflammatory cytokines, causing cytotoxic and vasogenic oedema, which acts as an 
epileptogenic foci in dying phase of cyst.
 
Diagnostic criteria for solitary cerebral cysticercus granuloma (SCCG)
(29) 
Clinical criteria 
1. Seizure as initial symptom (partial or generalized). 
2. No features of persistent raised ICT. 
3. No evidence of progressive neurologic deficit 
               4. No evidence of active systemic illness like tuberculosis and/or focus of pyogenic 
infections, primary malignancy. 
CT criteria: 
1.  solitary lesion 
2. Should enhance after contrast injection 
3.  <20mm in diameter 
4. Absence of severe cerebral edema. 
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Management of SSECTL: AED therapy is the mainstay of treatment. An addition 
of short course of oral prednisolone (1mg/kg/day for ten days followed by tapering 
over 2 weeks) helps in prevention of seizure recurrence and also in early 
disappearance of lesion.
(25)
 After a period of 10- 12 weeks follow up CT scan 
should be done in every patient to document the resolution of granuloma. If the 
patient has not had a seizure in the preceding 3 months, soon after a documented 
resolution of granuloma early discontinuation of AEDs is recommended.
(29) 
If the lesion enlarges in size on follow up CT scan Anti tuberculous therapy 
(ATT) may be considered.  
If clinically malignancy is suspected Surgical excision of the enlarging 
lesion for histopathological examination is recommended, as SSECTL in few 
patients could be due to meningioma and other primary bone tumours.
(29) 
NEUROCYSTICERCOSIS 
It is a common parasitic disease of the CNS. Neurocysticercosis is caused by 
‘cysticercus cellulose’ the encysted larval stage of the tapeworm TaeniaSolium. 
For many years the parenchymal cysts may remain dormant and the death of larva 
and subsequent intense inflammatory reaction induced by larval antigens produces 
symptoms (e.g. seizures). Subsequently, the cyst transforms into active granuloma. 
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The cyst then shrinks and granuloma eventually calcify or frequently disappears 
completely.
(30)
          
In brain parenchyma, the cysticercus cyst typically goes through four stages 
of involution 
1) Vesicular 
2) Colloidal 
3) Granular – nodular and 
4) Calcific. 
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The first 2 stages are considered to represent the live parasite, and last two stages, 
the dying or dead forms of the parasite. A live cyst is asymptomatic, evolving no or 
minimal host immune response. 
In India, majority of patients of neurocysticercosis have single enhancing lesions 
but the multiple enhancing CT/MRI lesions are also not uncommon
(31)
. These 
single or multiple lesions pose a challenge to clinicians and radiologists. The 
clinical features and imaging of neurocysticercosis and tuberculoma are 
exceedingly similar and it is difficult to differentiate these two conditions.
(32) 
The distinction between tuberculoma and single cysticercus granuloma is  
important  because single cysticercus granuloma is a benign and self limiting 
condition, but tuberculoma is an active infection which requires prolonged therapy 
with potentially toxic drugs.
(33) 
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a
Diagnosis is confirmed by either one absolute criteria or a combination of 2 major 
criteria, one minor criteria, and one epidemiologic criteria. A probable diagnosis is 
supported by the fulfillment of (1) one major criteria plus two minor criteria; (2) 
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one major criteria plus one minor criteria and one epidemiologic criteria; or (3) 
three minor criteria plus one epidemiologic criteria. 
Unequivocal evidence of neurocysticercosis is histopathological demonstration of 
the parasite. 
Following lesions are highly suggestive of neurocysticercosis in 
neuroimaging, solitary cysticercus granuloma ,spontaneous resolution or eventual 
calcification  after several months.
(34) 
Electroimmuno transfer blot (EITB)assay is the current serological assay of 
choice for the diagnosis of neurocysticercosis. This assay has a specificity of 100% 
and a sensitivity of 94% to 98% for patients with 2 or more cystic or enhancing 
lesions. But frequent false negative results in patients with a solitary intracranial 
cysticercus lesion, in whom less than 50% test positive. The sensitivity and 
specificity of EITB is also low in patients with calcified lesions.
(35) 
CSF ELISA for neurocysticercosis is 95% specific and 87% sensitive . It is a 
useful supportive tool for the diagnosis . But in contrast Serum ELISA has a large 
number of false negative and false positive results. 
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TUBERCULOMA OF BRAIN 
            It  account for 20 to 30% of intracranial space occupying lesions in 
India
(36)
.Tuberculoma develop in brain when the initial ―Rich focus‖ does not 
rupture into the meninges but expands locally with in the brain parenchyma. It may 
also originate in the meninges, and may be found in the superficial cortex. This 
meningeal form may resemble a meningioma.
(37)
 
Patients with tuberculoma most often present with seizures (60 to 100%), 
signs and symptoms of raised ICT (56- 93%) and focal neurological deficits (33- 
68%).Tuberculomas may also be multiple or military.
(38) 
There may be multiple caseating  granulomas in the brain, although most of 
the patients (66- 73%) have single or multiple large granulomas with 
necrotic centre.
(39) 
Imaging features: 
During the initial phase, edema and necrosis may appear as low attenuating 
areas on CT scan., There may be high attenuation, contrast enhancement and 
calcification associated with ring enhancement and a surrounding edema when the 
granuloma has began to organize. This may be homogenous enhancement  or  there 
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may be a central radiolucent area  which corresponds to a central zone of 
necrosis.
(40) 
 MRI is  more sensitive than CT in detecting cerebral parenchymal 
tubercuoma. Tuberculoma are isointense with gray matter on T1 weighted images. 
Lesions show central hyper intensity on T2 weighted images.A hypointense ring is 
present within the wall of tuberculoma on T2 weighted MR images in some cases. 
Tuberculomas typically ―enhance‖ after  administration of IV gadopentetate 
dimeglumine in a solid or ring pattern.
(41) 
SEIZURES IN PATIENTS WITH HIV: 
 CNS involvement in AIDS patients may first be manifested by seizures
(42)
. seizure 
threshold is often lower than normal in these patient due to the frequent presence 
of electrolyte abnormalities  Seizures are seen in 15- 35% of patients with primary 
CNS lymphoma 15- 40% of patients with cerebral toxoplasmosis, 7- 50% of 
patients with HIV encephalopathy and  8% of patients with cryptococcal 
meningitis
(43)
. The most common cause of enhancing CT/MRI lesions in patients 
with AIDS isToxoplasmosis. Seizures have been reported as an early symptom of 
CNS tuberculosis in 50% patients
(44)
 . 
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Both  generalized  and focal seizures were noted in patients with focal brain 
lesions and in those where no cause for seizures could be identified. Presence of 
focal seizure did not necessarily imply the presence of focal brain lesion.
(45) 
Recurrences of seizures have been observed in 68% of patients despite of 
anticonvulsant therapy. It is difficult to predict which patient is likely to have 
recurrent seizures. While looking for a cause of seizures in patients with HIV 
infection, investigation should include CT/MRI scan, serological test for 
toxoplasmosis and CSF examination for cryptococcal antigen, adenosine 
deaminase and fungal culture.
(45) 
Differential Diagnosis of Seizures 
In most cases seizures can be distinguished from other conditions by careful 
attention to the history and relevant laboratory studies. Additional studies such as  
video-EEG monitoring, cardiac electrophysiology, sleep studies, tilt-table analysis 
may be required to reach a correct diagnosis. Disorders that may mimic seizure are 
listed below, 
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Mechanisms of Action of Antiepileptic Drugs 
AED’s appear to act primarily by blocking the initiation or spread of 
seizures.Through a variety of mechanisms by which they modify the activity of ion 
channels or neurotransmitters and these  drugs also have pleiotropic effects in most 
of the cases. The mechanisms include  
1) inhibition of  sodium dependent action potentials in a frequency-dependent 
manner (e.g., carbamazepine, phenytoin, lamotrigine, rufinamide,  
topiramate, zonisamide, lacosamide), 
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2) inhibition of voltage-gated calcium channels (phenytoin, 
pregabalin,gabapentin),  
3) attenuation of glutamate activity (lamotrigine, felbamate, topiramate), 
4)  potentiation of GABA receptor function (benzodiazepines and barbiturates), 
5)  increase in the availability of GABA (valproic acid, tiagabine,gabapentin), 
and 
6) modulation of release of synaptic vesicles (levetiracetam).  
  The most effective drugs for absence seizures, valproic acid and ethosuximide 
probably act by inhibiting T-type calcium channels in thalamic neurons. 
Treatment of Seizure: 
When a patient presents shortly after a seizure,we should give first priorities to 
vital signs, cardiovascular and respiratory support, and treatment of seizures. Life-
threatening conditions such as metabolic derangement, CNS infection, or drug 
toxicity must be managed appropriately. 
If patient is not acutely ill,the initial evaluation focus on whether there is a history 
of earlier seizures. If this is the first seizure, then the emphasis will be : (1) to 
establish whether the reported episode was a seizure or any another paroxysmal 
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event, (2) to determine the cause of the seizure by identifying precipitating events  
and risk factors, and (3)  to decide whether anticonvulsant therapy is required. 
 
a
As adjunctive therapy. 
AED Selection for  Focal Seizures 
Carbamazepine, lamotrigine and phenytoin is currently the initial drug of 
choice for the treatment of focal seizures, including those that secondarily 
generalize. Overall, these drugs have very similar efficacy, but differences in 
toxicity and pharmacokinetics  are the main determinants for use in a given patient. 
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Phenytoin offers the advantage of once or twice daily dosing because it has a 
relatively long half- life compared to two or three times daily dosing for 
carbamazepine and lamotrigine. An advantage of carbamazepine is that the 
relationship between drug dose, serum levels, is linear because of its metabolism 
follows first- order pharmacokinetics.By contrast, small increases in dose of 
phenytoin above a standard maintenance dose can precipitate marked side effects 
because its properties of saturation kinetics. This is the main causes of acute 
phenytoin toxicity. The long- term use of phenytoin is associated with cosmetic 
effects (e.g., hirsutism, gingival hypertrophy and coarsening of facial features), and 
it is often avoided in young patients who require the drug for many years because 
of its effects on bone metabolism. Carbamazepine can cause aplastic anemia, 
leucopenia, or hepatotoxicity.Therefore it would be contraindicated in patients with 
predispositions to these problems. Lamotrigine may cause skin rash during the 
initiation of therapy. Sometimes it can be extremely severe and may lead to 
Stevens - Johnson syndrome if the symptoms unrecognized and if the medication is 
not discontinued immediately. Slow introduction and titration may decreases the 
risk. 
Valproic acid is an effective alternative for some patients with focal 
seizures, especially when the seizures secondarily generalize. GI side effects are 
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fewer when using the valproate semisodium formulation. Valproic acid also rarely 
causes hepatotoxicity and reversible bone marrow suppression and laboratory 
testing is required to monitor toxicity.In patients with preexisting bone marrow or 
liver disease this drug should be avoided. 
Topiramate, levetiracetam, tiagabine, zonisamide, gabapentin, and 
oxcarbazepine are additional drugs currently used for the treatment of focal 
seizures with or without secondary generalization.Previously, phenobarbital and 
other barbiturate compounds were commonly used as first - line therapy for most 
of epilepsy
(58) 
. 
AED Selection for Generalized Seizures 
Currently Valproic acid is the best initial choice for the treatment of 
primarily generalized, tonic- clonic seizures. Followed by Lamotrigine,  phenytoin 
and carbamazepine  are suitable alternatives. Valproic acid is also effective in 
absence, atonic and myoclonic seizures.Therefore it is the drug of choice in 
patients with generalized epilepsy syndromes having mixed seizure types.Both 
carbamazepine and phenytoin can worsen certain types of generalized seizures, 
including myoclonic, absence, tonic, and atonic seizures.In uncomplicated absence 
seizures ethosuximide is a particularly effective drug for the treatment, but it is not 
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useful for tonic- clonic or focal seizures. Periodic monitoring of blood cell counts 
is required in ethosuximide therapy because it rarely causes bone marrow 
suppression.Zonisamide, topiramate, and felbamate may have similar broad 
efficacy. 
Initiation and Monitoring of Therapy 
Patients should be carefully educated about the approach to therapy because 
the response to any antiepileptic drug is unpredictable. The goal is to prevent 
seizures and minimize the side effects of therapy; determination of the optimal 
dose may take months or longer if the baseline seizure frequency is low. Most 
anticonvulsant drugs
(59)
 need to be introduced relatively slowly to minimize side 
effects. Patients should expect that minor side effects such as slight changes in 
cognition,mild sedation or imbalance would typically resolve within a few days. 
Subsequent increase in dose should be made only after achieving a steady state 
with the previous dose. 
Monitoring of serum AED levels can be very useful for establishing the 
initial dosing schedule.The key determinants are the clinical measures of seizure 
frequency and presence of side effects and not the laboratory values. Serum drug 
levels measured by Conventional assays measure the total drug (that is both free 
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and protein- bound forms).The concentration of free drug that reflects extracellular 
levels in the brain and correlates with efficacy. Patients with decreased levels of 
serum proteins (i.e., decreased serum albumin due to impaired liver or renal 
function) may have an increased ratio of free to protein bound drug, yet the 
concentration of free drug may be adequate for seizure control. These patients may 
have a ―subtherapeutic‖ drug level, but the dose should be changed only when 
seizures remain uncontrolled, not just to achieve a ―therapeutic‖ level.  
If seizures continue despite gradual increases to the maximum tolerated 
dose and documented compliance, then it becomes necessary to switch to another 
AED. This is usually done by maintaining the patient on
(60)
 the first drug while a 
second drug is added. The second drug should be adjusted to reduce the seizure 
frequency and also without causing toxicity. If this is achieved, the first drug can 
be gradually withdrawn. The dose of the second drug is then further optimized 
based on seizure response and side effects. Anyhow monotherapy should be the 
goal. 
When to Discontinue Therapy 
Overall, about 70% of children and 60% of adults who have their seizures 
completely controlled with AED’s can eventually discontinue therapy. The 
 
 
50 
 
following profile of patient yields the greatest chance of remaining seizure- free 
after the drug withdrawal: 
 (1) complete medical control of seizures for one to five years; 
 (2) single seizure type, either generalized or partial; 
            (3) normal neurologic examination;  
           (4) normal EEG.  
The appropriate seizure- free interval is unknown and it varies for different forms 
of epilepsy. However, it seems reasonable to attempt withdrawal of therapy after 2 
years in a patient who meets all of the above criteria, is motivated to discontinue 
the medication. In most cases, it is preferable to reduce the dose of the drug 
gradually over two to three months. Most recurrences occur in the first three 
months after discontinuing therapy. So patients should be advised to avoid 
potentially dangerous situations such as swimming or driving during this period.
(61)
 
Treatment of Refractory Epilepsy 
Approximately one - third of patients with epilepsy do not respond to 
treatment with a single antiepileptic drug, so it becomes necessary to try a 
combination of drugs to control seizures. Patients with multiple seizure types and 
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developmental delay or those who have focal epilepsy related to an underlying 
structural lesion are particularly likely to require multiple drugs.The initial 
combination therapy combines first- line drugs, i.e., carbamazepine, valproic acid, 
phenytoin and lamotrigine. If these drugs are unsuccessful, then add a newer drug 
such as topiramate or levetiracetam. Patients with myoclonic seizures resistant to 
valproic acid then add clonazepam, and those with absence seizures may respond 
to a combination of ethosuximide and valproic acid. 
Surgical Treatment of Refractory Epilepsy 
Approximately 20% of patients with epilepsy are resistant to medical 
therapy. For some, surgery can be extremely effective in substantially reducing 
seizure frequency and even providing complete seizure control. Surgical options 
are Lesionectomy, Temporal Lobectomy Hemispherectomy Corpus 
CallosotomySelective Amygdalohippocampectomy Minimal Access, Stereotactic 
ablations, Cerebellar stimulation, and Vagus nerve stimulation. 
 Status Epilepticus 
 It refers to continuous seizures or repetitive, discrete seizures with impaired level 
of consciousness in the interictal period. It  has numerous subtypes, including 
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generalized convulsive status epilepticus (GCSE) and nonconvulsive status 
epilepticus. To meet the definition of status epilepticus the duration of seizure 
activity has to be15–30 minutes. But, the duration of seizures prompts the acute 
use of anticonvulsant therapy in status epilepticus. For GCSE, this is typically 
when seizures last beyond 5 minutes. 
Generalized convulsive status epilepticus is an emergency and must be treated 
immediately, since hyperthermia,cardiorespiratory dysfunction and metabolic 
derangements can occur as a consequence of prolonged seizures.These can lead to 
irreversible neuronal injury. Furthermore, CNS injury can also occur when the 
patient is paralyzed with neuromuscular blockade but continues to have 
electrographic seizures. CNS tumors, anticonvulsant withdrawal or 
noncompliance, metabolic disturbances, drug toxicity, refractory epilepsy, CNS 
infection,  and head trauma are most common causes of GCSE. 
GCSE is obvious when the patient is having overt convulsions. After 30–45 
minutes of uninterrupted seizures, the signs become increasingly subtle. 
Sometimes patients may have , fine rapid movements of the eyes and mild clonic 
movements of only the fingers. There may be paroxysmal episodes of 
hypertension,  tachycardia and pupillary dilation. In these cases, the EEG is the 
only method of establishing the diagnosis.If the patient stops having overt seizures, 
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yet remains comatose, an EEG must be performed to rule out ongoing status 
epilepticus. 
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AIM OF THE STUDY: 
     To analyse the clinical profile and to evaluate the patients with new onset 
seizures who presented to KMCH 
  
MATERIALS AND METHODS 
This is a Descriptive study conducted in Government Kilpauk medical college 
hospital, Department of medicine in collaboration with Neurology department, for 
a period of  9months. A total of 100 cases  admitted in medical ward with new 
onset seizures were selected for the present study from March 2013 to November 
2013. 
 
Materials: 
     Detailed history, physical examination, ,RFT,Sr.Electrolytes ,EEG, CT 
Brain,MRI Brain, CSF, serology and other routine investigations. 
METHODOLOGY: In patients with New onset seizures along with history and 
clinical examination, special investigations like CT BRAIN, MRI BRAIN,EEG, 
SEROLOGY, CSF ANALYSIS will be done to find out the etiology. 
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INCLUSION CRITERIA: 
Patients admitted in medical wards of Govt. Kilpauk medical college hospital, 
- Age more than 18 years. 
- New onset seizures  (Provoked and unprovoked ) 
- Status Epilepticus 
EXCLUSION CRITERIA: 
- Psychogenic seizures. 
- Eclampsia 
Data collection 
The data of each patient was collected on a proforma specially designed for this 
study and included demographic details, detailed history, clinical features, past 
medical history.  physical examination, RFT, Sr.Electrolytes, EEG, CT Brain ,MRI 
Brain and other routine investigations. 
Statistical Tools 
The information collected regarding all the selected cases were recorded in a 
Master Chart. Data analysis was done with the help of computer using statistics 
software. 
 
 
56 
 
Using this software range, frequencies, percentages, means, standard  
deviations, chi square and 'p' values were calculated. Kruskul Wallis chi-square 
test was used to test the significance of difference between quantitative variables 
and Yate’s test for qualitative variables. A 'p' value less than 0.05 is taken to 
denote significant relationship. 
OBSERVATION AND ANALYSIS : 
   The results of the study are shown in tables as below. The baseline characteristics 
observed are as follows, 
Number of cases of new onset seizures studied -100 
Table 1: Age and sex distribution 
 AGE IN YEARS  MALE           FEMALE        TOTAL 
1 <20 3 10 13 
2 21 - 30 21 5 26 
3 31 - 40 13 7 20 
4 41 - 50 8 10 18 
5 51 - 60 7 9 16 
6 61 - 70 3 4 7 
 TOTAL 55 45 100 
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In the present study patients age ranged from 18yrs to 80 years with the mean of  
Majority of patients were in the age group of 21-30yrs(n=26) followed by 31to 40 
yrs(n=20). 
          77% of patients were in 2
nd
 – 5th decade. 6%of patients were in the age group 
of >60yrs.  
FIGURE-1 
 
Majority of males were in 3
rd
  decade and females were in 5
th
 decade. 
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Out of 100 patients 55 were males and 45 were females with male to female ratio 
of 1.22 : 1. 
Table 2:etiologies and sex  distribution 
ETIOLOGY MALE (n=55) FEMALE 
(n=45) 
P value 
ALCOHOL 
WITHDRAWAL(n=34) 
31 3  
 
 0.001 
IDIOPATHIC (n=29) 13 16 
NEURO INFECTION (n=16) 6 10 
CVA (n=12) 4 8 
METABOLIC ( n=9) 1 8 
Among etiologies and sex distribution the P vaue is <0.001. This  shows there is 
significant correlation between etiologies and sex  distribution in this study. 
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   FIGURE-2
 
Table 3: distribution of etiologies in patients with seizures 
 
ETIOLOGIES NUMBER (n=100) P value 
1 ALCOHOL WITHDRAWL 34 
 
 
<0.001 
2 IDIOPATHIC 29 
3 NEURO INFECTION 16 
4 CVA 12 
5 METABOLIC 9 
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Among distribution of various etiologies in seizures shows the P value of <0.001. 
This shows there is significant relation among distribution of various etiologies in 
seizures. 
Alcohol withdrawal is leading cause of seizure,which accounted for 34% followed 
by Idiopathic 29%, Neuro infection 16%,CVA 12% and metabolic 9% 
FIGURE-3 
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  Table -4:correlation of etiologies with age group 
 ETIOLOGIES                   AGE IN YEARS  
  18-20 21- 30 31-40 41-50 51-60 61- 70 P value 
1 ALCOHOL 
WITHDRAWAL 
0 11 8 8 5 2  
 
 
<0.001 
2 IDIOPATHIC 9 9 7 2 1 1 
3 NEURO 
INFECTION 
4 6 3 0 1 2 
4 CVA 0 0 2 5 5 0 
5 METABOLIC 0 0 2 2 2 2 
Alcohol withdraeal seizures is more common in 21-30 years.whereas CVA and 
metabolic seizures are common in older people. 
In 18-20 yrs 69%is due to idiopathic,31%is due to neuro infection. 
In 21-30 yrs most common etiology is 42%alcohol withdrawal followed by 35% 
idiopathic and 23% neuroinfection. 
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In 31-40 yrs most common etilogy is alcohol withdrawal 36% followed by 
idiopathic 31%, neuroinfection 14%, CVA9%, metabolic 9% 
In 41-50 yrs most common etiology is alcohol withdrawal 47% followed by CVA 
29%,idiopathic 12% and metabolic 12% 
In50-60yrs most common etiology is alcohol withdrawal36% and CVA 36% 
followed by metabolic 19%, idiopathic%, neuroinfection 7%   
In age >60 yrs most commo etiology is neuroinfection and metabolic seizures 29% 
followed by 28%alcohol withdrawal and14% idiopathic. 
The P value of etiologies and age distribution is <0.001.This shows there is 
significant correlation between etiologies and age distribution of this study. 
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FIGURE-4
 
Table -5: various types of neuro infection 
 NEURO INFECTION NUMBER(n=16) %AMONG 
NEURO 
INFECTION 
1 TUBERCULOMA 6 37.5 
2 NEUROCYSTICERCOSIS 4 25 
3 MENINGITIS 2 12.5 
4 MENINGOENCEPHALITIS 3 18.75 
5 CEREBRAL MALARIA 1 6.25 
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Among neuro infection Tuberculoma accounts for 
37.5%(6),neurocysticercosis4(25%),meningitis 2(12.5%),meningoencephalitis 
3(18.75%),cerebral malaria 1(6.25). 
 
FIGURE-5
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Table 6:Various types of CVA 
 CVA NUMBER(n=12) % AMONG 
CVA 
1 INFARCT 5 41.67 
2 HAEMORRHAGE 3 25 
3 CVT 1 8.33 
4 SAH 2 16.67 
5 SDH 1 8.33 
Among CVA  infarct 5( 42%),haemorrhage3(25%),CVT1(8%),SAH2(17%) and 
SDH1(8%) 
FIGURE-6
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Table 7: various metabolic causes 
 METABOLIC CAUSE NUMBER 
(n=9) 
%AMONG 
METABOLIC 
CAUSE 
1 HYPOGLYCAEMIA 5 55.56 
2 HYPERGLYCAEMIA 1 11.11 
3 HYPOCALCAEMIA 1 11.11 
4 HYPONATRAEMIA 2 22.22 
Among metabolic causes 56% is due to hypoglycaemia followed by hyponatremia 
22%,hyperglycemia and hypocalcemia 11% 
.FIGURE-7
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Table 8:Association for etiology and type of seizures 
 ETIOLOGY TYPE OF SEIZURE P value 
  GTCS FOCAL 
1 ALCOHOL 
WITHDRAWAL 
28 6  
 
<0.001 
2 IDIOPATHIC 21 8 
3 NEURO INFECTION 8 8 
4 CVA 9 3 
5 METABOLIC 4 5 
 TOTAL 70 30 
The P value of <0.001 shows there is significant relation between etiology and type 
of seizures in this study. 
Seizures are commmonly present as GTCS.Most of the Alcohol withdrawal 
seizures 28(82%) are present as GTCS. 
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FIGURE-8.
 
Table 9: GTCS distribution 
ETIOLOGY NUMBER OF CASES 
(n=70) 
ALCOHOL WITHDRAWAL 28 
IDIOPATHIC 21 
CVA 9 
NEURO INFECTION 8 
METABOLIC 4 
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GTCS common in alcohol withdrawal seizures 40% folloed by idiopathic seizures 
30%. 
FIGURE-9
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Table 10: Focal seizures distribution 
ETIOLOGY NUMBER OF CASES(n=30) 
ALCOHOL WITHDRAWAL 6 
IDIOPATHIC 8 
CVA 3 
NEURO INFECTION 8 
METABOLIC 5 
Focal seizures are common in neuroinfection and iddiopathic seizures. 
FIGURE-10
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DISCUSSION 
In this study, a total of  100 patients with new onset epilepsy were included. 
Sex ratio: 
            There was a slight male preponderance (M: F=1.22:1) in this study as 
quoted by other studies on epilepsy in United States and Europe (Granieri et 
al,1983). 
Age distribution: 
Maximum number of patients were in age group of 18- 40 years, the 
youngest being 18 years.Alcohol withdrawal seizures  and adult onset idiopathic 
seizures are more common in this age group. Epilepsy due to cerebral infections 
like neurocysticercosis, tuberculoma and brain abscess are common in middle age. 
Type of seizures: generalized tonic clonic seizures 70% are more common than 
focal seizures 30% in this study. 
Etiology of epilepsy 
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In our study Alcohol withdrawal seizures (34%) was the commonest cause, 
followed by idiopathic epilepsy (29%), Neuro infection (16%),CVA(12%) and 
Metabolic seizures(9%).It was very difficult to differentiate between tuberculoma 
and NCC based on CT findings. We did chest X ray PA view and TB ELISA for 
patients suspected of tuberculoma. There was a history of chronic cough in one 
patient. Another patient who was diagnosed to have pulmonary tuberculosis 1 year 
ago had taken anti tubercular drugs for about 3 months and had presented with 
generalized tonic clonic convulsions. The CT scan showed 3 large ring enhancing 
lesions which were more than 20 mm in size. 
It should be emphasized that despite careful investigations, a sizable 
proportion of patients (34%) were diagnosed as alcohol withdrawal seizures.  
Etiologies observed in various stidies 
1)SANDER et al(1990) UK 
VASCULAR 15% 
TUMOUR 6% 
INFECTION 2% 
ALCOHOL RELATED 9% 
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2)HAUSER et al (1995)USA 
CVA 18% 
NEURO INFECTION 15% 
TRAMATIC BRAIN INJURY 13% 
TUMOUR 13% 
ALCOHOL WITHDRAWAL 11% 
METABOLIC 10% 
 
3) MURTHY JMK and RAVI (1999)Hyderabad 
NEUROINFECTION 77% 
VASCULAR 14% 
METABOLIC 3% 
TUMOUR 7% 
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4)NARAYANAN JT and JMK (2007) 
NEUROINFECTION 32% 
VASCULAR 21% 
METABOLIC 32% 
ALCOHOL 9% 
OTHERS  15% 
 
In present study: 
 ETIOLOGIES NUMBER 
(n=100) 
1 ALCOHOL WITHDRAWL 34 
2 IDIOPATHIC 29 
3 NEURO INFECTION 16 
4 CVA 12 
5 METABOLIC 9 
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 GTCS FOCAL 
SEIZURES 
1)SANDER et al 39% 61% 
2)MURTHY JMK and RAVI Y 22% 78% 
3)NARAYANAN JT 55% 45% 
4)OUR STUDY 70% 30% 
 In our study: 
  Most of Alcohol withdrawal seizure patients presented with GTCS(82%) 
 72% Of  idiopathic seizure patients presented with GTCS  followed by focal 28% 
50% Of neuro infection patients presented with GTCS and focal seizures 50% 
75% Of CVA  patients presented with GTCS followed by focal seizures25% 
 54%Of  metabolic seizure patients presented with focal seizures followed by 
GTCS. 
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                                         CONCLUSION 
From the present study ―CLINICAL PROFILE AND EVALUATION OF NEW 
ONSET SEIZURES‖the following conclusions were made. 
1.Underlying etiologies were made in acute symptomatic seizures which 
contributed to 79%. 
2.Majority of seizures occurred in patients <50 yrs of age. 
3. Etiological spectrum were varied and included alcohol withdrawal,neuro 
infection,CVA,metabolic. 
4. Alcohol withdrawal accounted for significant number of seizures in all the age 
groups. 
5.Tuberculoma is most common cause of seizures in neuroinfection. 
6.Infarct is most common cause of seizures in CVA patients. 
7. Hypoglycemia is an important cause of seizures in metabolic seizures. 
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SUMMARY 
This Descriptive study was done in the KMC hospital to know the  various 
etiologies.100 cases of new onset seizures who fulfilled the criteria as mentioned in 
materials and methods were included in the study. 
Out of 100 patients 55% were males,45%were females with male to female ratio of 
1.2:1. 
Majority of males were in 2
nd
 decade and females were in 4
th
 decade.patients age 
ranged from 18 yrs to 80 yrs,with the mean of  40.11yearswith 77% of the patients 
were in the below 50 yrs. 
Alcohol withdrawal  was the leading xcause of seizureswhich account for 34% 
followed by idiopathic seizures (29%),neuro infection (16%),CVA 12% and 
metabolic (9%). 
Among  neuro infection tuberculoma acconted for  followed by neurocysticrcosis 
25%,meningitis13%,meningoencephalitis 19% and cerebral malaria 6%. 
Among CVA infarct accounted for 42% followed by haemorrhage 25%,SAH 
17%,SDH 8% and CVT 8%. 
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Among metabolic causes hypoglycemia accounted for 56% followed by 
hyponatraemia 22% ,hyperglycemia 11% and hypocalcemia 11%. 
GTCS was the most common seizure 70%.Most common cause of GTCS was 
alcohol withdrawal 40%followed by idiopathic 30%,CVA 13%,neuro 
infection11%,metabolic 6%. 
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                      LIST OF ABBREVATIONS USED 
AED Antiepileptic Drug 
CT Computerized Tomography 
EEG Electroencephalo Gram 
EITBA Electroimmuno Transfer Blot Assay 
ELISA Enzyme Linked Immunosorbent Assay 
FNAC Fine Needle Aspiration Cytology 
GABA Gamma Amino Butyric Acid 
GTCS Generalized Tonic Clonic Seizures 
HIV Human Immunodeficiency Virus 
MRI Magnetic Resonance Imaging 
NCC Neurocysticercosis 
PCDD Primary Cerebral Degenerative Disorder 
PCR Polymerase Chain Reaction 
RBS Random Blood Sugar 
SCCG Solitory Cerebral Cysticercal Granuloma 
SSECL Single Small Enhancing CT Lesion 
TIA Transient Ischemic Attack 
 
 
88 
 
 
 
PROFORMA 
NAME :                                                                          DIAGNOSIS: 
AGE/SEX: 
OCCUPATION: 
ADDRESS: 
DETAILS OF PRESENT ILLNESS: 
SEIZURES: 
 Time of onset 
 Duration 
 Aura 
 Any precipitating factors 
 Partial   ( face/ hand/ upper limb/ lower limb/ foot ) 
 Generalised ( LOC, tongue bite, bladder/bowel  incontinence, post ictal 
confusion, residual neurological deficit ) 
 Number of episodes 
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ASSOCIATED COMPLAINTS: 
 Fever 
 Headache 
 Vomiting 
 Focal neurological deficit 
 Head injury 
 
PAST HISTORY: DM-2 / SHT /TB / CVA / Meningitis / Encephalitis / RHD 
FAMILY HISTORY: DM-2/SHT/Seizure disorder/Mental retardation 
PERSONAL HISTORY: Sleep,Diet, Smoking, Alcoholism,Drug abuse, 
Tobacco chewing 
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GENERAL EXAMINATION: 
- Built & nourishment: 
- Height:                   weight:                     BMI: 
- P/I/CY/CL/LN/PE 
- VITALS- PR.BP,RR,TEMPERATURE 
- Cutaneous stigmata of neuroepidermal syndromes  
                    -adenoma sebaceum,  
                    -café-au-lait spots,  
                    -neurofibromatosis,  
                    -ash leaf macules, 
                    -shagreen patch 
 
SYSTEMIC EXAMINATION 
 Central nervous system 
- Higher functions   : 
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- Cranial nerves       : 
- Motor system         : 
- Sensory system      : 
- Reflexes                 : 
- Autonomic nervous system : 
- Skull & spine         : 
- Meningeal signs     : 
 Cardiovascular system 
 Respiratory system 
 Abdominal system 
INVESTIGATIONS:  
 CBC – TC,DC, ESR, Hb,Platelet count. 
 BIOCHEMISTRY:- 
                              - RBS,FBS,PPBS 
                               -B.Urea, S.Creatinine., 
                               -Serum electrolytes( Na, K, Ca) 
 URINE ROUTINE EXAMINATION---sugar,albumin, deposits 
 CHEST X-RAY 
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 HIV - ELISA 
 CSF ANALYSIS- appearance, pressure,sugar, protein, cell count, gram 
stain, cytology, culture 
 EEG 
 CT- BRAIN 
 MRI- BRAIN 
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